ArticleAmerican journal of hematology2017

Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.

Patrick T Griffin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.